Clinical trial on reducing oxidative stress and inflammatory responsewith San Huang Decoction on the breast cancer patients during perioperative period

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-IIR-17011612

Enrollment

Unknown

Registered

2017-06-09

Start date

2015-04-01

Completion date

Unknown

Last updated

2017-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

breast cancer

Interventions

Experimental group:The SHD decoction + basal treatment

Control group:Basal treatment

Eligibility

Sex/Gender

Female

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: all patients had to have a diagnosis of breast cancer with planned modified radical surgery aged from 18 to 70 years old.

Exclusion criteria

Exclusion criteria: Patients with other types of surgery instead of modified radical surgery, metastatic breast cancer, serious internal organ diseases and/or accepting oral anticoagulation and suppressive anti-inflammatory medicines like aspirin and steroids were excluded from the study.

Design outcomes

Primary

Measure	Time frame
CRP;IL-2R;IL-8;TNF-a;	—

Countries

China

Contacts

Public ContactYao Chang

Affiliated Hospital of Nanjing University of TCM

yaochang67@126.com+86 13770549638

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026